MEIP Starts Phase II Study on Pracinostat MEI Pharma, Inc. commenced a phase II study of Pracinostat in combination with Vidaza (azacitidine) for the treatment of myelodysplastic syndrome (MDS)
June 19, 2013 - Zacks via Yahoo! Finance
MEIP Starts Phase II Study on Pracinostat - Analyst Blog MEI Pharma, Inc. ( MEIP ) recently commenced a phase II study of Pracinostat in combination with Vidaza (azacitidine) for the treatment of myelodysplastic syndrome (MDS). The
June 19, 2013 - Nasdaq
Jaden Smith in Scottish Daily Record Jaden recalled: "I was just walking up to Mei Ying, it's the first time I ever see her, and boom, my knee was just killing me."
Alan Mulally in StreetInsider.com (subscription) Mei-Wei is an exceptional leader who has been pivotal to the success we're experiencing within our China operations today,said Alan Mulally, Ford president and CEO. "He has led the team responsible for growing Ford's brand and product...